- Home
- TELA vs ECOR Comparison
TELA vs ECOR Comparison
Compare TELA & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- ECOR
- Stock Information
- Founded
- TELA 2012
- ECOR 2005
- Country
- TELA United States
- ECOR United States
- Employees
- TELA N/A
- ECOR N/A
- Industry
- TELA Medical/Dental Instruments
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TELA Health Care
- ECOR Health Care
- Exchange
- TELA Nasdaq
- ECOR Nasdaq
- Market Cap
- TELA 104.0M
- ECOR 110.4M
- IPO Year
- TELA 2019
- ECOR 2018
- Fundamental
- Price
- TELA $2.72
- ECOR $17.67
- Analyst Decision
- TELA Strong Buy
- ECOR Strong Buy
- Analyst Count
- TELA 4
- ECOR 1
- Target Price
- TELA $9.25
- ECOR $25.00
- AVG Volume (30 Days)
- TELA 186.3K
- ECOR 104.7K
- Earning Date
- TELA 03-20-2025
- ECOR 03-12-2025
- Dividend Yield
- TELA N/A
- ECOR N/A
- EPS Growth
- TELA N/A
- ECOR N/A
- EPS
- TELA N/A
- ECOR N/A
- Revenue
- TELA $68,649,000.00
- ECOR $23,327,000.00
- Revenue This Year
- TELA $30.39
- ECOR $59.81
- Revenue Next Year
- TELA $25.51
- ECOR $38.49
- P/E Ratio
- TELA N/A
- ECOR N/A
- Revenue Growth
- TELA 29.34
- ECOR 74.10
- 52 Week Low
- TELA $2.30
- ECOR $5.32
- 52 Week High
- TELA $7.18
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- TELA 50.00
- ECOR 55.62
- Support Level
- TELA $2.53
- ECOR $15.83
- Resistance Level
- TELA $2.96
- ECOR $19.43
- Average True Range (ATR)
- TELA 0.13
- ECOR 1.19
- MACD
- TELA 0.02
- ECOR 0.17
- Stochastic Oscillator
- TELA 44.19
- ECOR 58.06
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.